Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept TrialKatja Weisel,Britta Besemer,Mathias Haenel,Raphael Lutz,Christoph Mann,Markus Munder,Martin Goerner,Hans Christian Reinhardt,Axel Nogai,Yon-Dschun Ko,Maike De Wit,Hans Salwender,Christoph Scheid,Ullrich Graeven,Rudolf Peceny,Peter Staib,Annette Dieing,Anna Jauch,Manola Zago,Axel BennerBlood（2022）引用 3|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
